Associations between Circumstances Surrounding Overdose and Underlying Classes of Polysubstance Overdose Deaths

References

• Akaike, H. (1974). A new look at the statistical model identification. IEEE Transactions on Automatic Control, 19(6), 716–723. https://doi.org/10.1109/TAC.1974.1100705
   Web of Science ®Google Scholar
• Arminger, G., Stein, P., & Wittenberg, J. (1999). Mixtures of conditional mean- and covariance-structure models. Psychometrika, 64(4), 475–494. https://doi.org/10.1007/BF02294568
   Web of Science ®Google Scholar
• Asparouhov, T., & Muthén, B. (2014). Auxiliary variables in MIXTURE modeling: Three-step approaches using Mplus. Structural Equation Modeling: A Multidisciplinary Journal, 21(3), 329–341. https://doi.org/10.1080/10705511.2014.915181
   Web of Science ®Google Scholar
• Asparouhov, T., & Muthén, B. (2022). Multiple imputation with Mplus—statmodel.com. Stat Model. Retrieved June 27, 2022, from https://www.statmodel.com/download/Imputations7.pdf
   Google Scholar
• Barocas, J. A., Wang, J., Marshall, B. D. L., LaRochelle, M. R., Bettano, A., Bernson, D., Beckwith, C. G., Linas, B. P., & Walley, A. Y. (2019). Sociodemographic factors and social determinants associated with toxicology confirmed polysubstance opioid-related deaths. Drug and Alcohol Dependence, 200, 59–63. https://doi.org/10.1016/j.drugalcdep.2019.03.014
   PubMed Web of Science ®Google Scholar
• CDC. (2021a). Understanding the epidemic. Centers for Disease Control and Prevention. Retrieved April 15, 2022, from https://www.cdc.gov/drugoverdose/epidemic/index.html
   Google Scholar
• CDC. (2021b). Products—data briefs—number 403—March 2021. Centers for Disease Control and Prevention. Retrieved August 3, 2022, from https://www.cdc.gov/nchs/products/databriefs/db403.htm#:∼:text=From%202016%20through%202019%2C%20age,to%2019.6%20(Figure%201)
   Google Scholar
• Ciccarone, D. (2021). The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis. Current Opinion in Psychiatry, 34(4), 344–350. https://doi.org/10.1097/yco.0000000000000717
   PubMed Web of Science ®Google Scholar
• Cicero, T. J., Ellis, M. S., & Kasper, Z. A. (2020). Polysubstance use: A broader understanding of substance use during the opioid crisis. American Journal of Public Health, 110(2), 244–250. https://doi.org/10.2105/ajph.2019.305412
   PubMed Web of Science ®Google Scholar
• Chichester, K., Drawve, G., Sisson, M., McCleskey, B., Dye, D. W., & Cropsey, K. (2020). Examining the neighborhood-level socioeconomic characteristics associated with fatal overdose by type of drug involved and overdose setting. Addictive Behaviors, 111, 106555. https://doi.org/10.1016/j.addbeh.2020.106555
   PubMed Web of Science ®Google Scholar
• Compton, W. M., Valentino, R. J., & DuPont, R. L. (2021). Polysubstance use in the U.S. opioid crisis. Molecular Psychiatry, 26(1), 41–50. https://doi.org/10.1038/s41380-020-00949-3
   PubMed Web of Science ®Google Scholar
• Congdon, P. (2020). Geographical aspects of recent trends in drug-related deaths, with a focus on intra-national contextual variation. International Journal of Environmental Research and Public Health, 17(21), 8081. https://doi.org/10.3390/ijerph17218081
   PubMed Web of Science ®Google Scholar
• Dai, Z., Abate, M. A., Long, D. L., Smith, G. S., Halki, T. M., Kraner, J. C., & Mock, A. R. (2020). Quantifying enhanced risk from alcohol and other factors in polysubstance-related deaths. Forensic Science International, 313, 110352. https://doi.org/10.1016/j.forsciint.2020.110352
   PubMed Web of Science ®Google Scholar
• Dunnett, C. W. (1955). A multiple comparison procedure for comparing several treatments with a control. Journal of the American Statistical Association, 50(272), 1096–1121. https://doi.org/10.1080/01621459.1955.10501294
   Web of Science ®Google Scholar
• Easterling, K. W., Mack, K. A., & Jones, C. M. (2016). Location of fatal prescription opioid-related deaths in 12 states, 2008–2010: Implications for prevention programs. Journal of Safety Research, 58, 105–109. https://doi.org/10.1016/j.jsr.2016.07.004
   PubMed Web of Science ®Google Scholar
• Figgatt, M. C., Austin, A. E., Cox, M. E., Proescholdbell, S., Marshall, S. W., & Naumann, R. B. (2021). Trends in unintentional polysubstance overdose deaths and individual and community correlates of polysubstance overdose, North Carolina, 2009-2018. Drug and Alcohol Dependence, 219, 108504. https://doi.org/10.1016/j.drugalcdep.2020.108504
   PubMed Web of Science ®Google Scholar
• Giglio, R. E., Li, G., & DiMaggio, C. J. (2015). Effectiveness of bystander naloxone administration and overdose education programs: A meta-analysis. Injury Epidemiology, 2(1), 10. https://doi.org/10.1186/s40621-015-0041-8
   PubMedGoogle Scholar
• Goldman‐Hasbun, J., Nosova, E., Kerr, T., Wood, E., & DeBeck, K. (2019). Homelessness and incarceration associated with relapse into stimulant and opioid use among youth who are street‐involved in Vancouver, Canada. Drug and Alcohol Review, 38(4), 428–434. https://doi.org/10.1111/dar.12921
   PubMed Web of Science ®Google Scholar
• Golladay, M., Donner, K., & Nechuta, S. (2020). Using statewide death certificate data to understand trends and characteristics of polydrug overdose deaths in Tennessee, 2013–2017. Annals of Epidemiology, 41, 43–48.e1. https://doi.org/10.1016/j.annepidem.2019.12.001
   PubMed Web of Science ®Google Scholar
• Han, B., Compton, W. M., Jones, C. M., Einstein, E. B., & Volkow, N. D. (2021). Methamphetamine use, methamphetamine use disorder, and associated overdose deaths among us adults. JAMA Psychiatry, 78(12), 1329–1342. https://doi.org/10.1001/jamapsychiatry.2021.2588
   PubMed Web of Science ®Google Scholar
• Hargrove, S. L., Bunn, T. L., Slavova, S., Quesinberry, D., Corey, T., Ralston, W., Singleton, M. D., & Ingram, V. (2018). Establishment of a comprehensive drug overdose fatality surveillance system in Kentucky to inform drug overdose prevention policies, interventions and best practices. Injury Prevention, 24(1), 60–67. https://doi.org/10.1136/injuryprev-2016-042308
   PubMed Web of Science ®Google Scholar
• Holland, K. M., DePadilla, L., Gervin, D. W., Parker, E. M., & Wright, M. (2021). The evolution of the overdose epidemic and CDC’s research response: A commentary. Drugs in Context, 10, 1–4. https://doi.org/10.7573/dic.2021-8-2
   Google Scholar
• Hoots, B., Vivolo‐Kantor, A., & Seth, P. (2020). The rise in non‐fatal and fatal overdoses involving stimulants with and without opioids in the United States. Addiction, 115(5), 946–958. https://doi.org/10.1111/add.14878
   PubMed Web of Science ®Google Scholar
• Kariisa, M., Davis, N. L., Kumar, S., Seth, P., Mattson, C. L., Chowdhury, F., & Jones, C. M. (2022). Vital signs: Drug overdose deaths, by selected sociodemographic and social determinants of health characteristics—25 states and the District of Columbia, 2019–2020. MMWR. Morbidity and Mortality Weekly Report, 71(29), 940–947. https://doi.org/10.15585/mmwr.mm7129e2
   PubMed Web of Science ®Google Scholar
• Kariisa, M., Seth, P., Scholl, L., Wilson, N., & Davis, N. L. (2021). Drug overdose deaths involving cocaine and psychostimulants with abuse potential among racial and ethnic groups—United States, 2004–2019. Drug and Alcohol Dependence, 227, 109001. https://doi.org/10.1016/j.drugalcdep.2021.109001
   PubMed Web of Science ®Google Scholar
• Konefal, S., Sherk, A., Maloney-Hall, B., Young, M., Kent, P., & Biggar, E. (2022). Polysubstance use poisoning deaths in Canada: An analysis of trends from 2014 to 2017 using Mortality Data. BMC Public Health, 22(1), 1–12. https://doi.org/10.1186/s12889-022-12678-z
   Google Scholar
• Korona-Bailey, J. A., Nechuta, S., Golladay, M., Moses, J., Bastasch, O., & Krishnaswami, S. (2021). Characteristics of fatal opioid overdoses with stimulant involvement in Tennessee: A descriptive study using 2018 State Unintentional Drug Overdose Reporting System Data. Annals of Epidemiology, 58, 149–155. https://doi.org/10.1016/j.annepidem.2021.03.004
   PubMed Web of Science ®Google Scholar
• Li, C. (2013). Little’s test of missing completely at random. The Stata Journal: Promoting Communications on Statistics and Stata, 13(4), 795–809. https://doi.org/10.1177/1536867X1301300407
   Google Scholar
• Lim, J. K., Earlywine, J. J., Bagley, S. M., Marshall, B. D., & Hadland, S. E. (2021). Polysubstance involvement in opioid overdose deaths in adolescents and young adults, 1999-2018. JAMA Pediatrics, 175(2), 194–196. https://doi.org/10.1001/jamapediatrics.2020.5035
   PubMed Web of Science ®Google Scholar
• Lo, Y., Mendell, N., & Rubin, D. (2001). Testing the number of components in a normal mixture. Biometrika, 88(3), 767–778. https://doi.org/10.1093/biomet/88.3.767
   Web of Science ®Google Scholar
• Mattson, C. L., O’Donnell, J., Kariisa, M., Seth, P., Scholl, L., & Gladden, R. M. (2018). Opportunities to prevent overdose deaths involving prescription and illicit opioids, 11 states, July 2016–June 2017. MMWR. Morbidity and Mortality Weekly Report, 67(34), 945–951. https://doi.org/10.15585/mmwr.mm6734a2
   PubMed Web of Science ®Google Scholar
• Mattson, C. L., Tanz, L. J., Quinn, K., Kariisa, M., Patel, P., & Davis, N. L. (2021). Trends and geographic patterns in drug and synthetic opioid overdose deaths—United States, 2013–2019. MMWR. Morbidity and Mortality Weekly Report, 70(6), 202–207. https://doi.org/10.15585/mmwr.mm7006a4
   PubMed Web of Science ®Google Scholar
• Mimiaga, M. J., Closson, E. F., Pantalone, D. W., Safren, S. A., & Mitty, J. A. (2019). Applying behavioral activation to sustain and enhance the effects of contingency management for reducing stimulant use among individuals with HIV infection. Psychology, Health & Medicine, 24(3), 374–381. https://doi.org/10.1080/13548506.2018.1515492
   PubMed Web of Science ®Google Scholar
• Muthén, L. K., & Muthén, B. O. (2013). Mplus user’s guide (7th ed.). Muthén & Muthén.
   Google Scholar
• NCHS. (2022, July 22). Drug overdose deaths. NCHStats. Retrieved July 29, 2022, from https://nchstats.com/category/drug-overdose-deaths/
   Google Scholar
• NHCHC. (n.d.). Opioid policy priorities—nhchc.org. The Opioid Epidemic and Homelessness: An Action Agenda for the HCH Community. Retrieved August 4, 2022, from https://nhchc.org/wp-content/uploads/2019/08/opioid-policy-priorities_-endorsing-organizations-docx.pdf
   Google Scholar
• O’Donnell, J., Gladden, R. M., Mattson, C. L., Hunter, C. T., & Davis, N. L. (2020). Vital signs: Characteristics of drug overdose deaths involving opioids and stimulants—24 states and the District of Columbia, January–June 2019. MMWR. Morbidity and Mortality Weekly Report, 69(35), 1189–1197. https://doi.org/10.15585/mmwr.mm6935a1
   PubMed Web of Science ®Google Scholar
• Otiashvili, D., Mgebrishvili, T., Beselia, A., Vardanashvili, I., Dumchev, K., Kiriazova, T., & Kirtadze, I. (2022). The impact of the COVID-19 pandemic on illicit drug supply, drug-related behaviour of people who use drugs and provision of drug related services in Georgia: Results of a mixed methods prospective cohort study. Harm Reduction Journal, 19(1), 1–15. https://doi.org/10.1186/s12954-022-00601-z
   Google Scholar
• NRHA. (2015). Rural health policy development and advocacy—NRHA. The Future of Rural Behavioral Health. Retrieved August 4, 2022, from https://www.ruralhealth.us/NRHA/media/Emerge_NRHA/Advocacy/Government%20affairs/2022/2022-NRHA-Policy-Development-Guide.pdf
   Google Scholar
• Park, J. N., Schneider, K. E., Fowler, D., Sherman, S. G., Mojtabai, R., & Nestadt, P. S. (2022). Polysubstance overdose deaths in the fentanyl era: A latent class analysis. Journal of Addiction Medicine, 16(1), 49–55. https://doi.org/10.1097/adm.0000000000000823
   PubMed Web of Science ®Google Scholar
• Peppin, J. F., Raffa, R. B., & Schatman, M. E. (2020). The polysubstance overdose-death crisis. Journal of Pain Research, 13, 3405–3408. https://doi.org/10.2147/JPR.S295715
   PubMed Web of Science ®Google Scholar
• Rhee, T. G., Ross, J. S., Rosenheck, R. A., Grau, L. E., Fiellin, D. A., & Becker, W. C. (2019). Accidental drug overdose deaths in Connecticut, 2012–2018: The rise of polysubstance detection? Drug and Alcohol Dependence, 205, 107671. https://doi.org/10.1016/j.drugalcdep.2019.107671
   PubMed Web of Science ®Google Scholar
• Ropero-Miller, J. D., Smiley‐McDonald, H. M., Zimmer, S. A., & Bollinger, K. M. (2020). A census of medicolegal death investigation in the United States: A need to determine the state of our nation’s toxicology laboratories and their preparedness for the current drug overdose epidemic. Journal of Forensic Sciences, 65(2), 544–549. https://doi.org/10.1111/1556-4029.14277
   PubMed Web of Science ®Google Scholar
• S.B. 463. (Nev. 2019). Biennium, 2019 Reg. Session. https://www.leg.state.nv.us/App/NELIS/REL/80th2019/Bill/6875/Text
   Google Scholar
• Schneider, K. E., Nestadt, P. S., Shaw, B. R., & Park, J. N. (2021). Trends in substances involved in polysubstance overdose fatalities in Maryland, USA 2003–2019. Drug and Alcohol Dependence, 223, 108700. https://doi.org/10.1016/j.drugalcdep.2021.108700
   PubMed Web of Science ®Google Scholar
• Schwarz, G. (1978). Estimating the dimension of a model. The Annals of Statistics, 6(2), 1–11. https://doi.org/10.1214/aos/1176344136
   Web of Science ®Google Scholar
• Shiue, K. Y., Austin, A. E., Proescholdbell, S., Cox, M. E., Aurelius, M., & Naumann, R. B. (2021). Literal text analysis of poly-class and polydrug overdose deaths in North Carolina, 2015–2019. Drug and Alcohol Dependence, 228, 109048. https://doi.org/10.1016/j.drugalcdep.2021.109048
   PubMed Web of Science ®Google Scholar
• Weller, B., Bowen, N., & Faubert, S. (2020). Latent class analysis: A guide to best practice. Journal of Black Psychology, 46(4), 287–311. https://doi.org/10.1177/0095798420930932
   Web of Science ®Google Scholar
• Zastepa, E., Sun, J. C., Clune, J., & Mathew, N. (2020). Adaptation of contingency management for stimulant use disorder during the COVID-19 pandemic. Journal of Substance Abuse Treatment, 118, 108102. https://doi.org/10.1016/j.jsat.2020.108102
   PubMed Web of Science ®Google Scholar